SCHEMBL21875108

SCHEMBL21875108

Cc1cnc(CNC(=O)c2ccn(S(=O)(=O)c3ccccc3)c2)cn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 1/20 0.52
▸ KLKB1 P03952 5/20 0.52
▸ P2RX3 P56373 5/20 0.47
▸ P2RX2 Q9UBL9 5/20 0.47
▸ NAMPT P43490 3/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.43
▸ TUBB4A P04350 1/20 0.43
▸ TUBB P07437 1/20 0.43
▸ TUBA3C P0DPH7 1/20 0.43
▸ TUBA1B P68363 1/20 0.43
▸ TUBA4A P68366 1/20 0.43
▸ TUBB4B P68371 1/20 0.43
▸ TUBB3 Q13509 1/20 0.43
▸ TUBB2A Q13885 1/20 0.43
▸ TUBB8 Q3ZCM7 1/20 0.43
▸ TUBA3E Q6PEY2 1/20 0.43
▸ TUBA1A Q71U36 1/20 0.43
▸ TUBA1C Q9BQE3 1/20 0.43
▸ TUBB6 Q9BUF5 1/20 0.43
▸ TUBB2B Q9BVA1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21875069 0.91 NAMPT (0.48) KLKB1P2RX3P2RX2NAMPT
SCHEMBL21875096 0.90 KLKB1 (0.50) KLKB1P2RX3P2RX2NAMPT
SCHEMBL21875093 0.89 NAMPT (0.46) KLKB1NAMPTWDR5
SCHEMBL21875086 0.88 KLKB1 (0.49) KLKB1P2RX3P2RX2NAMPTWDR5
SCHEMBL21875164 0.88 KLKB1 (0.60) KLKB1NAMPT
SCHEMBL21875087 0.87 P2RX3 (0.44) KLKB1P2RX3P2RX2NAMPTWDR5
SCHEMBL21875145 0.87 PKM (0.52) PKMKLKB1P2RX3P2RX2NAMPT
SCHEMBL21875127 0.87 GRM4 (0.47) KLKB1P2RX3P2RX2NAMPTWDR5
SCHEMBL21875078 0.87 NAMPT (0.44) KLKB1P2RX3P2RX2NAMPTWDR5
SCHEMBL21875065 0.85 WDR5 (0.47) KLKB1P2RX3P2RX2NAMPTWDR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113056461-A Arylsulfonyl pyrrole carboxamide derivatives as Kv3 potassium channel activators H.隆德贝克有限公司 2021-06-29 — — CN claimed
US-20200131156-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS H. LUNDBECK A/S (DK) 2020-04-30 — — US claimed
CN-113056461-A Arylsulfonyl pyrrole carboxamide derivatives as Kv3 potassium channel activators H.隆德贝克有限公司 2021-06-29 — — CN disclosed
US-20200131156-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS H. LUNDBECK A/S (DK) 2020-04-30 — — US disclosed
US-20200131156-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS H. LUNDBECK A/S (DK) 2020-04-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131156-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS KCNA3, KCNN3, KCNK3 PKM 394/4885KLKB1 784/4885P2RX3 198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback